BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32985066)

  • 1. Immunological effects of Chondrus armatus carrageenans and their low molecular weight degradation products.
    Cicinskas E; Begun MA; Vikhareva VV; Karetin YA; Kalitnik AA
    J Biomed Mater Res A; 2021 Jul; 109(7):1136-1146. PubMed ID: 32985066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antitumor and immunotropic activity of carrageenans from red algae Chondrus armatus and their low-molecular weight degradation products.
    Cicinskas E; Begun MA; Tiasto VA; Belousov AS; Vikhareva VV; Mikhailova VA; Kalitnik AA
    J Biomed Mater Res A; 2020 Feb; 108(2):254-266. PubMed ID: 31606930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus.
    Zhou G; Sun Y; Xin H; Zhang Y; Li Z; Xu Z
    Pharmacol Res; 2004 Jul; 50(1):47-53. PubMed ID: 15082028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low molecular lambda-carrageenan from Chondrus ocellatus on antitumor H-22 activity of 5-Fu.
    Zhou G; Sheng W; Yao W; Wang C
    Pharmacol Res; 2006 Feb; 53(2):129-34. PubMed ID: 16310373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. κ- and λ-Carrageenans from Marine Alga
    Tiasto VA; Goncharov NV; Romanishin AO; Zhidkov ME; Khotimchenko YS
    Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulating Properties of Carrageenan from Tichocarpus crinitus.
    Cicinskas E; Kalitnik AA; Karetin YA; Mohan Ram MSG; Achary A; Kravchenko AO
    Inflammation; 2020 Aug; 43(4):1387-1396. PubMed ID: 32212036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carrageenans on the binding, phagocytotic, and killing abilities of macrophages to salmonella.
    Sugita-Konishi Y; Yamashita S; Amano F; Shimizu M
    Biosci Biotechnol Biochem; 2003 Jun; 67(6):1425-8. PubMed ID: 12843678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo growth-inhibition of S180 tumor by mixture of 5-Fu and low molecular lambda-carrageenan from Chondrus ocellatus.
    Zhou G; Xin H; Sheng W; Sun Y; Li Z; Xu Z
    Pharmacol Res; 2005 Feb; 51(2):153-7. PubMed ID: 15629261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides.
    Yuan H; Song J; Li X; Li N; Dai J
    Cancer Lett; 2006 Nov; 243(2):228-34. PubMed ID: 16410037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of carrageenan on peritoneal macrophages.
    Vijayakumar RK; Palanivel V; Muthukkaruppan VR
    Immunol Lett; 1989 Nov; 23(1):55-9. PubMed ID: 2691395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To gel or not to gel: differential expression of carrageenan-related genes between the gametophyte and tetasporophyte life cycle stages of the red alga Chondrus crispus.
    Lipinska AP; Collén J; Krueger-Hadfield SA; Mora T; Ficko-Blean E
    Sci Rep; 2020 Jul; 10(1):11498. PubMed ID: 32661246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological changes following systemic injection of purified carrageenans (kappa, lambda and iota).
    Davidson RJ; Simpson JG; Whiting PH; Milton JI; Thomson AW
    Br J Exp Pathol; 1981 Oct; 62(5):529-39. PubMed ID: 7295547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by xylan and carrageenan-type polysaccharides from red seaweeds: Anti-inflammatory, wound healing, cytoprotective, and anticoagulant activities.
    Premarathna AD; Ahmed TAE; Rjabovs V; Hammami R; Critchley AT; Tuvikene R; Hincke MT
    Int J Biol Macromol; 2024 Mar; 260(Pt 1):129433. PubMed ID: 38232891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelling polysaccharide from Chondrus armatus and its oligosaccharides: the structural peculiarities and anti-inflammatory activity.
    Kalitnik AA; Marcov PA; Anastyuk SD; Barabanova AO; Glazunov VP; Popov SV; Ovodov YS; Yermak IM
    Carbohydr Polym; 2015 Jan; 115():768-75. PubMed ID: 25439960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunochemistry of lambda-type carrageenans from certain red algae.
    DiNinno V; McCandless EL
    Carbohydr Res; 1978 Nov; 67(1):235-41. PubMed ID: 568513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase diagrams of hybrid carrageenans extracted from Ahnfeltiopsis devoniensis and Chondrus crispus.
    Torres MD; Azevedo G; Hilliou L
    Carbohydr Polym; 2016 Jan; 136():449-58. PubMed ID: 26572375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of a phage-display recombinant antibody against carrageenans: evidence for the recognition of a secondary structure of carrageenan chains present in red algae tissues.
    Liners F; Helbert W; Van Cutsem P
    Glycobiology; 2005 Sep; 15(9):849-60. PubMed ID: 15872149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondrus crispus treated with ultrasound as a polysaccharides source with improved antitumoral potential.
    Torres MD; Flórez-Fernández N; Domínguez H
    Carbohydr Polym; 2021 Dec; 273():118588. PubMed ID: 34560989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of carrageenans from Chondrus crispus.
    Matsuhiro B; Urzua CC
    Phytochemistry; 1992 Feb; 31(2):531-4. PubMed ID: 1367970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrageenan: a review of its effects on the immune system.
    Thomson AW; Fowler EF
    Agents Actions; 1981 May; 11(3):265-73. PubMed ID: 7020378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.